SUPERNUS PHARMACEUTICALS, INC. (SUPN) — Federal Contracts & Tech Stack
SUPERNUS PHARMACEUTICALS, INC. (SUPN) is an active recipient of U.S. federal and defense procurement awards. According to federal procurement records and obligation filings, the company has been awarded 0 prime federal contracts and delivery orders totaling approximately $0 across 1 federal awarding agencies, with the most recent award action registered on —.
Federal contracts represent substantial multi-year revenue visibility for prime contractors and defense suppliers. Gemral Edge continuously reconciles federal award obligations from the Federal Procurement Data System (FPDS) and USAspending with congressional disclosures, tracking capital flow from policy authorization through corporate execution.
Verified from official public disclosure — record SUPN-CONGRESS-DISCLOSURE
Quick Facts & Defense Contracting Direct Answers
How much does SUPERNUS PHARMACEUTICALS, INC. receive in federal government contracts?
SUPERNUS PHARMACEUTICALS, INC. has been awarded over $0 in tracked prime federal obligations across 1 awarding agencies, as recorded in official FPDS and USAspending data.
Which congressional lawmakers trade SUPERNUS PHARMACEUTICALS, INC. (SUPN) stock?
Public Periodic Transaction Reports (PTR) under the STOCK Act record transactions in SUPERNUS PHARMACEUTICALS, INC. (SUPN) by congressional lawmakers and affiliated accounts.
How are federal defense contracts mapped to SUPERNUS PHARMACEUTICALS, INC. on Gemral Edge?
Gemral Edge programmatically reconciles prime award obligations from SAM.gov, USAspending, and FPDS through corporate parent CAGE and UEI hierarchies directly to ticker SUPN.
Unified Ticker Intelligence Dossier (SUPN)
Synthesis: Mã SUPN ghi nhận dữ liệu hoạt động tổng hợp qua các kênh công quyền và dòng tiền.
Temporal Context: Ghi nhận sự kiện và luồng thông tin mới trong 365 ngày qua đối với SUPN.
Data Coverage & Verification: Overall coverage score: 42% across 6 pillars (Government, Policy, Flow, Management, Catalysts, Historical). Verified by 2 independent statutory data sources.
Congressional Stock Trading Activity in SUPN
Disclosed stock purchases and sales by members of Congress and spouses involving SUPERNUS PHARMACEUTICALS, INC. securities under the STOCK Act:
| Lawmaker | Party-State | Chamber | Transaction Date | Action | Disclosed Range | Est. Return |
|---|---|---|---|---|---|---|
| Josh Gottheimer | D-NJ | HOUSE | 2020-05-28 | BUY | $1K – $15K | +70.0% |
Related Congressional Committees & Active Lawmakers
Disclosed lawmakers and congressional committees holding policy jurisdiction, defense appropriations oversight, or direct capital exposure in SUPN:
- Josh Gottheimer (House) — Disclosed STOCK Act transactions (D-NJ)
- Nancy Pelosi (House) — Former Speaker of the House (D-CA)
- George Whitesides (House) — House Science, Space & Technology Committee (D-CA)
- Tommy Tuberville (Senate) — Senate Armed Services Committee (R-AL)
- Cory Booker (Senate) — Senate Foreign Relations Committee (D-NJ)
- Ro Khanna (House) — House Armed Services Committee (D-CA)
Latest Real-Time Intelligence & Breaking Events
Live contract obligations, SEC filings, and procurement intelligence for SUPERNUS PHARMACEUTICALS, INC. are monitored 24/7 on Gemral Edge Breaking News and Defense Radar.
Federal Contracting Dynamics & Government Revenue Exposure
Government contracting for defense and enterprise infrastructure follows strict Federal Acquisition Regulation (FAR) guidelines, often spanning multi-year base periods with optional extension years. Monitoring prime contractor award velocity provides institutional investors and market participants with un-lagged visibility into backlog expansion, agency budget priorities, and defense authorization funding flows.
Furthermore, when members of congressional defense, intelligence, or appropriations committees disclose trading activity in major federal contractors such as SUPERNUS PHARMACEUTICALS, INC., cross-referencing contract award timelines with legislative disclosures highlights important intersections of public policy and corporate performance.
Frequently asked questions
How much does SUPERNUS PHARMACEUTICALS, INC. receive in federal government contracts?
SUPERNUS PHARMACEUTICALS, INC. holds over $0 in tracked federal obligations across 1 public agencies, providing multi-year revenue visibility across defense and civilian procurement budgets.
Which congressional lawmakers trade SUPERNUS PHARMACEUTICALS, INC. (SUPN) stock?
SUPERNUS PHARMACEUTICALS, INC. (SUPN) stock transactions have been disclosed by members of Congress. Disclosures filed under the STOCK Act detail execution dates, asset classes, and statutory valuation ranges.
How are federal defense contracts resolved to SUPERNUS PHARMACEUTICALS, INC.?
Gemral Edge maps prime award notices from the Federal Procurement Data System (FPDS) and USAspending through Ultimate Parent CAGE and UEI corporate hierarchies directly to parent ticker SUPN.
What technology stack signals are detected for SUPERNUS PHARMACEUTICALS, INC.?
Active talent hiring requisitions and engineering role profiles are continuously monitored across public corporate job postings to track enterprise software adoption and technology migration patterns.
Data intelligence from public filings — not investment advice.
Explore Gemral Edge
- Josh Gottheimer — stock portfolio
- Nancy Pelosi — stock portfolio
- George Whitesides — stock portfolio
- Tommy Tuberville — stock portfolio
- Cory Booker — stock portfolio
- Ro Khanna — stock portfolio
- Capitol Trades leaderboard
- Federal contract explorer
- Lobbying velocity index
- Live signal radar
- Macro & liquidity radar
- 2026 Senate battleground